Logo image of ESBL.CA

ESHBAL FUNCTIONAL FOOD INC (ESBL.CA) Stock Fundamental Analysis

TSX-V:ESBL - TSX Venture Exchange - CA2959181066 - Common Stock - Currency: CAD

0.27  +0.01 (+3.85%)

Fundamental Rating

2

Taking everything into account, ESBL scores 2 out of 10 in our fundamental rating. ESBL was compared to 0 industry peers in the Unkown industry. ESBL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ESBL has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ESBL had negative earnings in the past year.
ESBL had a negative operating cash flow in the past year.
ESBL had negative earnings in each of the past 5 years.
In the past 5 years ESBL always reported negative operating cash flow.
ESBL.CA Yearly Net Income VS EBIT VS OCF VS FCFESBL.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -50K -100K -150K -200K

1.2 Ratios

Industry RankSector Rank
ROA -29.35%
ROE -31.16%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ESBL.CA Yearly ROA, ROE, ROICESBL.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

ESBL does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ESBL.CA Yearly Profit, Operating, Gross MarginsESBL.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

More info and screens

6

2. Health

2.1 Basic Checks

ESBL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ESBL.CA Yearly Shares OutstandingESBL.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2M 4M 6M 8M 10M
ESBL.CA Yearly Total Debt VS Total AssetsESBL.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 200K 400K 600K 800K 1M

2.2 Solvency

ESBL has an Altman-Z score of 204.61. This indicates that ESBL is financially healthy and has little risk of bankruptcy at the moment.
There is no outstanding debt for ESBL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 204.61
ROIC/WACCN/A
WACCN/A
ESBL.CA Yearly LT Debt VS Equity VS FCFESBL.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200K 400K 600K 800K 1M

2.3 Liquidity

A Current Ratio of 17.15 indicates that ESBL has no problem at all paying its short term obligations.
ESBL has a Quick Ratio of 17.15. This indicates that ESBL is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 17.15
Quick Ratio 17.15
ESBL.CA Yearly Current Assets VS Current LiabilitesESBL.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 200K 400K 600K 800K 1M

More info and screens

1

3. Growth

3.1 Past

ESBL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -258.33%.
ESBL shows a strong growth in Revenue. In the last year, the Revenue has grown by 88.42%.
EPS 1Y (TTM)-258.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1925%
Revenue 1Y (TTM)88.42%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-47.06%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ESBL.CA Yearly Revenue VS EstimatesESBL.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 10K 20K 30K 40K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ESBL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ESBL.CA Price Earnings VS Forward Price EarningsESBL.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ESBL.CA Per share dataESBL.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.01 -0.01 -0.02

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ESBL does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ESHBAL FUNCTIONAL FOOD INC

TSX-V:ESBL (8/6/2025, 7:00:00 PM)

0.27

+0.01 (+3.85%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-22 2025-05-22
Earnings (Next)10-23 2025-10-23
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners4.86%
Ins Owner ChangeN/A
Market Cap18.40M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 426.99
P/FCF N/A
P/OCF N/A
P/B 21.18
P/tB 21.18
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -29.35%
ROE -31.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 17.15
Quick Ratio 17.15
Altman-Z 204.61
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-258.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1925%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)88.42%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-47.06%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-261.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-219.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-219.67%
OCF growth 3YN/A
OCF growth 5YN/A